Virtu Financial’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,923
Closed -$45K 1349
2023
Q4
$45K Buy
+17,923
New +$35.1K ﹤0.01% 1189
2023
Q2
Sell
-12,208
Closed -$37K 1455
2023
Q1
$37K Sell
12,208
-31,986
-72% -$90.2K ﹤0.01% 1148
2022
Q4
$103K Buy
+44,194
New +$106K 0.01% 953
2022
Q3
Sell
-52,722
Closed -$143K 1665
2022
Q2
$143K Buy
+52,722
New +$135K 0.01% 856
2021
Q3
Sell
-93,196
Closed -$282K 1439
2021
Q2
$282K Buy
93,196
+29,255
+46% +$90.6K 0.03% 762
2021
Q1
$213K Buy
63,941
+1,411
+2% +$5.45K 0.02% 1043
2020
Q4
$222K Buy
+62,530
New +$219K 0.02% 791
2020
Q3
Sell
-17,147
Closed -$31K 987
2020
Q2
$31K Buy
+17,147
New +$28.1K ﹤0.01% 1075
2019
Q3
Sell
-24,548
Closed -$51K 1387
2019
Q2
$51K Buy
+24,548
New +$62.8K ﹤0.01% 1228
2018
Q1
Sell
-11,287
Closed -$57K 1884
2017
Q4
$57K Buy
+11,287
New +$66.2K ﹤0.01% 2054

Other funds holding ABUS